ALTO-300 in Depression (ALTO-300-004)
NCT05157945 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 148
Last updated 2024-04-26
Summary
The purpose of this study is to collect biologically-based data for defining predictors and correlates of the effects of ALTO-300.
Conditions
Interventions
- DRUG
-
ALTO-300 PO Tablet
One tablet daily
Sponsors & Collaborators
-
Alto Neuroscience
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 74 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-03
- Primary Completion
- 2023-04-26
- Completion
- 2023-05-05
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Prospective Clinical Cohort Study of Depression
NCT05775809 ·Status: ENROLLING_BY_INVITATION
-
Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With Depression
NCT00178100 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Treatment for Depression in General Practice Using a Step-by-Step Care Plan.
NCT07263321 ·Status: RECRUITING ·Phase: NA
-
Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression
NCT00285766 ·Status: COMPLETED ·Phase: PHASE3
-
Depression and Dopamine Transporter Function Study Using C-11 Altropane
NCT01701141 ·Status: COMPLETED
-
Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly Individuals
NCT00178035 ·Status: COMPLETED ·Phase: PHASE4
-
Exploring Clinical Study Experiences of People With Depression
NCT05937932 ·Status: NOT_YET_RECRUITING
-
Comparing Various Treatments for Achieving and Maintaining Remission of Depression
NCT00227955 ·Status: COMPLETED ·Phase: PHASE4
-
Action Tendencies and Prognosis in Major Depressive Disorder
NCT04593537 ·Status: COMPLETED
-
A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Depression
NCT05850572 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
NCT05537558 ·Status: UNKNOWN
-
PERsonalized Mood Augmentation Trial for Depressed Mood
NCT05662254 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of Open-label Placebo to Treat Major Depressive Disorder
NCT01103271 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder
NCT04805879 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Treating Alcohol Use In Older Adults With Depression
NCT00018824 ·Status: COMPLETED ·Phase: PHASE4
-
Early Prediction of Fluoxetine Response
NCT01075529 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment-Resistant Depression Registry
NCT00320372 ·Status: COMPLETED
-
Rhythm and Depression
NCT02857036 ·Status: UNKNOWN ·Phase: NA
-
Antidepressant Incomplete Response Depression
NCT00782964 ·Status: COMPLETED
-
Post Marketing Study for the Evaluation of Predictix Antidepressant Clinician Software Support Tool in Prescribing Antidepressant Medication/s for the Treatment of Patients Suffering From Major Depressive Disorder
NCT04138290 ·Status: UNKNOWN ·Phase: PHASE4
-
Multidomain Intervention for Older Adults With Major Depressive Disorder
NCT03095820 ·Status: COMPLETED ·Phase: NA
-
Precision Care for Major Depressive Disorder
NCT06580041 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Treatment Resistant Depression in America Latina
NCT03207282 ·Status: COMPLETED
-
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
NCT02960763 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Health Care in Major Depressive Disorder
NCT05816018 ·Status: UNKNOWN